These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 786303)
1. [Further results of a multi-centre clinical trial with the oral antidiabetic drug glisoxepide (author's transl)]. Blumenbach L; Kiesselbach N; Lehnert J Arzneimittelforschung; 1976; 26(5):931-43. PubMed ID: 786303 [TBL] [Abstract][Full Text] [Related]
2. Blood glucose concentrations and glycosuria during and after one year of acarbose therapy. Aubell R; Boehme K; Berchtold P Arzneimittelforschung; 1983; 33(9):1314-8. PubMed ID: 6357206 [TBL] [Abstract][Full Text] [Related]
3. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). II. Proof of activity in the management of adult onset diabetes]. Blumenbach L; Kiesselbach NH; Lehnert J Arzneimittelforschung; 1974 Mar; 24(0):437-46. PubMed ID: 4603692 [No Abstract] [Full Text] [Related]
4. [Comparison of glibenclamide, gliquidone, glisoxepide and placebo in maturity onset diabetics of differing degrees of severity (author's transl)]. Irsigler K; Ogris E; Steinhardt T; Brändle J; Regal H; Zdolsek I Wien Klin Wochenschr; 1979 Aug; 91(16):541-50. PubMed ID: 115159 [TBL] [Abstract][Full Text] [Related]
6. A clinical trial with glipizide - a relative new sulphonylurea. Singarayar J; Sunderam S Med J Zambia; 1978; 12(4):97. PubMed ID: 398642 [TBL] [Abstract][Full Text] [Related]
7. [An absence of interaction of sulfametrol-trimethoprim with insulin or sulphonylurea derivatives in diabetics (author's transl)]. Kaspar L Wien Klin Wochenschr; 1980 Apr; 92(8):276-9. PubMed ID: 6996341 [TBL] [Abstract][Full Text] [Related]
8. [Clinico-pharmacological studies on the duration of action of the oral antidiabetic drug glisoxepide (author's transl)]. Gutsche H; Losert W Arzneimittelforschung; 1977; 27(9):1719-26. PubMed ID: 336058 [No Abstract] [Full Text] [Related]
9. [Clinical trial with glypentide. Comparison with the hypoglycemic activity of other sulfonylurea compounds]. López JM; Khoury G; Fernández RC; COBOS JM; Huelva JL Rev Iber Endocrinol; 1976; 23(134):181-96. PubMed ID: 778973 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus. Aman M; Jawad F; Sultana S; Waiz-ul-Haq ; Nanji R J Pak Med Assoc; 1977 Mar; 27(3):293-5. PubMed ID: 409862 [TBL] [Abstract][Full Text] [Related]
11. [Diabetes mellitus under 30 years of age. Results of 18 years experience with oral treatment (author's transl)]. Mirouze J; Cartry E Diabete Metab; 1975 Jun; 1(2):113-8. PubMed ID: 1234068 [TBL] [Abstract][Full Text] [Related]
12. [Diabetes therapy with a new antidiabetic Pro-Diaban]. Dols W Ther Ggw; 1976 Mar; 115(3):428-36. PubMed ID: 772866 [No Abstract] [Full Text] [Related]
13. [Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)]. Villiger U Schweiz Rundsch Med Prax; 1982 Apr; 71(16):699-704. PubMed ID: 7050960 [No Abstract] [Full Text] [Related]
14. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy. Bell DS Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL; Wolf SL; Kabadi UM Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835 [TBL] [Abstract][Full Text] [Related]
16. [Duration of effective hypoglycaemic action of glipizide given once daily (author's transl)]. Azzopardi J; Campbell IW; Clarke BF; Duncan LJ Med Klin; 1975 Jul; 70(28-29):1214-8. PubMed ID: 809650 [TBL] [Abstract][Full Text] [Related]
17. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent]. Pou Torelló JM; Vilaclara JM Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666 [No Abstract] [Full Text] [Related]